Popular Flu Drug may Pose Danger to Liver Health

Written by Greg Arnold, DC, CSCS. This study demonstrated that Tamiflu, when administered to rats, significantly increased ALT (liver enzyme) by 67.6% compared to control, and GGT by 71.9% in male rats and 49.8% in female rats compared to their respective controls. Researchers concluded that “using this drug [for flu prevention] would require a serious risk-to-benefit analysis, especially for high-risk patients.” (more…)